Prenatal diagnosis of Charcot-Marie-Tooth Disease type 1A by interphase fluorescence in situ hybridization

Prenatal Diagnosis

Volumn 19, Issue 5, 1999, Pages 446-449

  Kashork, Catherine D ^a   Lupski, James R ^a   Shaffer, Lisa G ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b NONE   (United States)

Author keywords

Chromosome 17; Duplication; FISH; Molecular cytogenetics; Peripheral neuropathy; Prenatal testing

Indexed keywords

ARTICLE; CHORION VILLUS SAMPLING; CHROMOSOME 17P; CHROMOSOME DUPLICATION; CLINICAL ARTICLE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; FETUS; FLUORESCENCE IN SITU HYBRIDIZATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

CHARCOT-MARIE-TOOTH DISEASE; CHORIONIC VILLI SAMPLING; FEMALE; FETAL DISEASES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 0032927898     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199905)19:5<446::AID-PD566>3.0.CO;2-O     Document Type: Article

References (31)

1. Chance PF, Bird TD, Matsunami N, Lensch MW, Brothman AR, Feldman GM. 1992. Trisomy 17p associated with Charcot-Marie-Tooth neuropathy type 1A phenotype: evidence for gene dosage as a mechanism in CMT1A. Neurology 42: 2295-2299.
2. Gabriel JM, Erne B, Pareyson D, Sghirlanzoni A, Taroni F, Steck AJ. 1997. Gene dosage effects in hereditary peripheral neuropathy. Expression of peripheral myelin protein 22 in Charcot-Marie-Tooth disease type 1A and hereditary neuropathy with liability to pressure palsies nerve biopsies. Neurology 49: 1635-1640.
3. Kaku DA, Parry GJ, Malamut R, Lupski JR, Garcia CA. 1993. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17. Neurology 43: 1806-1808.
4. King PH, Waldrop R, Lupski JR, Shaffer LG. 1998. Charcot-Marie-Tooth phenotype produced by a duplicated PMP22 gene as part of a 17p trisomy-translocation to the X chromosome. Clin Genet 54: 413-416.
5. Lebo RV. 1998. Prenatal diagnosis of Charcot-Marie-Tooth disease. Prenat Diagn 18: 169-172.
6. Lebo RV, Martelli L, Su Y, Li L, Lynch E, Mansfield E, Pua K-H, Watson DF, Chueh J, Hurko O. 1993. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A by multicolor in situ hybridization. Am J Med Genet 47: 441-450.
7. Lupski JR. 1996. DNA diagnostics for Charcot-Marie-Tooth disease and related inherited neuropathies. Clin Chem 42: 995-998.
8. Lupski JR, Chance PF, Garcia CA. 1993. Inherited primary peripheral neuropathies. Molecular genetics and clinical implications of CMT1A and HNPP. JAMA 270: 2326-2330.
9. Lupski JR, Garcia CA, Parry GJ, Patel PI. 1991a. Charcot-Marie-Tooth polyneuropathy syndrome: clinical, electrophysiological, and genetic aspects. In: Appel S (ed.) Current Neurology. Chicago: Mosby-Yearbook; 1-25.
10. Lupski JR, Montes de Oca-Luna R, Slaugenhaupt S, Pentao L, Guzzetta V, Trask BJ, Saucedo-Cardenas O, Barker DF, Killian JM, Garcia CA, Chakravarti A, Patel PI. 1991b. DNA duplication associated with Charcot-Marie-Tooth disease type 1A. Cell 66: 219-232.
11. Lupski JR, Wise CA, Kuwano A, Pentao L, Parke JT, Glaze DG, Ledbetter DH, Greenberg F, Patel PI. 1992. Gene dosage is a mechanism for Charcot-Marie-Tooth disease type 1A. Nature Genet 1: 29-33.
12. Matsunami N, Smith B, Ballard L, Lensch MW, Robertson M, Albertsen H, Hanemann CO, Müller HW, Bird TD, White R, Chance PF. 1992. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A. Nature Genet 1: 176-179.
13. Murakami T, Garcia CA, Reiter LT, Lupski JR. 1996. Charcot-Marie-Tooth disease and related inherited neuropathies. Medicine 75: 233-250.
14. Navon R, Timmerman V, Löfgren A, Liang P, Nelis E, Zeitune M, Van Broeckhoven C. 1995. Prenatal diagnosis of Charcot-Marie-Tooth disease type 1A (CMT1A) using molecular genetic techniques. Prenat Diagn 15: 633-640.
15. Nelis E, Van Broeckhoven C, Coauthors of the European Collaborative Study on CMT1. 1996. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study. Ear J Hum Genet 4: 25-33.
16. Niazi M, Coleman DV, Loeffler FE. 1981. Trophoblast sampling in early pregnancy. Culture of rapidly dividing cells from immature placental villi. Br J Obstet Gynaecol 88: 1081-1085.
17. Patel PI, Roa BB, Welcher AA, Schoener-Scott R, Trask BJ, Pentao L, Jackson Snipes G, Garcia CA, Francke U, Shooter EM, Lupski JR, Suter U. 1992. The gene for the peripheral myelin protein PMP-22 is a candidate for Charcot-Marie-Tooth disease type 1A. Nature Genet 1: 159-165.
18. Pellegrino JE, Pellegrino L, Spinner NB, Sladky J, Chance PF, Zackai EH. 1996. Developmental profile in a patient with monosomy 10q and dup(17p) associated with a peripheral neuropathy. Am J Med Genet 61: 377-381.
19. Pentao L, Wise CA, Chinault AC, Patel PI, Lupski JR. 1992. Charcot-Marie-Tooth type 1A duplication appears to arise from recombination at repeat sequences flanking the 1.5 Mb monomer unit. Nature Genet 2: 292-300.
20. Raeymaekers P, Timmerman V, Nelis E, De Jonghe P, Hoogendijk JE, Baas F, Barker DF, Martin JJ, De Visser M, Bolhuis PA, Van Broeckhoven C, HMSN Collaborative Research Group. 1991. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). Neuromuscular Disorders 1: 93-97.
21. Roa BB, Greenberg F, Gunaratne P, Sauer CM, Lubinsky MS, Kozma C, Meek JM, Magenis RE, Shaffer LG, Lupski JR. 1996. Duplication of the PMP22 gene in 17p partial trisomy patients with Charcot-Marie-Tooth type-1A neuropathy. Hum Genet 97: 642-649.
22. Shaffer LG. 1995. Diagnosis of microdeletion syndromes by fluorescence in situ hybridization (FISH). In: Dracopoli NC, Haines JL, Korf BR, Moir DT, Morton CC, Seidman CE, Seidman JG, Smith DR (eds) Current Protocols in Human Genetics, vol 1. New York: John Wiley & Sons, Inc. Unit 8.10.1.
23. Shaffer LG. 1997. Diagnosis of CMT1A duplications and HNPP deletions by fluorescence in situ hybridization: clinical considerations in neurology and oncology practices. In: Simmons A, Thielemann J (eds) The Molecular Genetic Diagnostic Review, Fall 1997. Houston: Baylor College of Medicine, Medical Genetics Laboratories; 1,5-7.
24. Shaffer LG, Kennedy GM, Spikes AS, Lupski JR. 1997. Diagnosis of CMT1A duplications and HNPP deletions by interphase FISH: implications for testing in the cytogenetics laboratory. Am J Med Genet 69: 325-331.
25. Timmerman V, Nelis E, Van Hul W, Nieuwenhuijsen BW, Chen KL, Wang S, Ben Othman K, Cullen B, Leach RJ, Hanemann CO, De Jonghe P, Raeymaekers P, van Ommen G-JB, Martin J-J, Müller HW, Vance JM, Fischbeck KH, Van Broeckhoven C. 1992. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication. Nature Genet 1: 171-175.
26. Upadhyaya M, Roberts SH, Farnham J, MacMillan JC, Clarke A, Heath JP, Hodges ICG, Harper PS. 1993. Charcot-Marie-Tooth disease 1A (CMT1A) associated with a maternal duplication of chromosome 17p11.2→12. Hum Genet 91: 392-394.
27. Valentijn LJ, Baas F, Wolterman RA, Hoogendijk JE, van den Bosch NHA, Zorn I, Gabreëls-Festen AAWM, de Visser M, Bolhuis PA. 1992. Identical point mutations of PMP-22 in Tremlber-J mouse and Charcot-Marie-Tooth disease type 1A. Nature Genet 2: 288-291.
28. Valentijn LJ, Baas F, Zorn I, Hensels GW, de Visser M, Bolhuis PA. 1993. Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A. Hum Mol Genet 2: 2143-2146.
29. Vallat J-M, Sindou P, Preux P-M, Tabaraud F, Milor A-M, Couratier P, LeGuern E, Brice A. 1996. Ultrastructural PMP22 expression in inherited demyelinating neuropathies. Ann Neurol 39: 813-817.
30. Wise CA, Garcia CA, Davis SN, Heju Z, Pentao L, Patel PI, Lupski JR. 1993. Molecular analyses of unrelated Charcot-Marie-Tooth (CMT) disease patients suggest a high frequency of the CMT1A duplication. Am J Hum Genet 53: 853-863.
31. Yoshikawa H, Nishimura T, Nakatsuji Y, Fujimura H, Himoro M, Hayasaka K, Sakoda S, Yanagihara T. 1994. Elevated expression of messenger RNA for peripheral myelin protein 22 in biopsied peripheral nerves of patients with Charcot-Marie-Tooth disease type 1A. Ann Neurol 35: 445-450.